Ronald C. Renaud JR - Insider Trading & Ownership

Entity
Individual
Location
C/O Idenix Pharmaceuticals, Inc., 60 Hampshire Street, Cambridge, MA
Summary
The estimated net worth of Ronald C. Renaud JR is at least $12.3K dollars as of October 15, 2024. Ronald C. Renaud JR is the Director of Atara Biotherapeutics, Inc. and owns shares of Atara Biotherapeutics, Inc. (ATRA) stock worth about $12.3K.
All Insider Reports
All Insider Reports

Ownership of Ronald C. Renaud JR

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ATRA Atara Biotherapeutics, Inc. Director $12.3K Jun 23, 2022
CERE Cerevel Therapeutics Holdings, Inc. President & CEO, Director $0 Aug 1, 2024
IKNA Ikena Oncology, Inc. Director Jun 9, 2022
TBIO Translate Bio, Inc. Chief Executive Officer, Director Sep 14, 2021
UPB Upstream Bio, Inc. Director Oct 10, 2024

Insider Transactions Reported by Ronald C. Renaud JR:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.